Trial · NCT02709538
Adverse events45
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 45
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | GSP 301 NS | 12 | 393 | 14 |
| other | Nasopharyngitis | Infections and infestations | GSP 301 Placebo NS pH 3.7 | 5 | 99 | 6 |
| other | Nasopharyngitis | Infections and infestations | GSP 301 Placebo NS pH 7.0 | 6 | 101 | 6 |
| other | Upper respiratory tract infection | Infections and infestations | GSP 301 NS | 25 | 393 | 30 |
| other | Upper respiratory tract infection | Infections and infestations | GSP 301 Placebo NS pH 3.7 | 6 | 99 | 8 |
| other | Upper respiratory tract infection | Infections and infestations | GSP 301 Placebo NS pH 7.0 | 9 | 101 | 12 |
| other | Headache | Nervous system disorders | GSP 301 NS | 16 | 393 | 18 |
| other | Headache | Nervous system disorders | GSP 301 Placebo NS pH 3.7 | 3 | 99 | 3 |
| other | Headache | Nervous system disorders | GSP 301 Placebo NS pH 7.0 | 5 | 101 | 5 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | GSP 301 NS | 18 | 393 | 23 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | GSP 301 Placebo NS pH 3.7 | 2 | 99 | 2 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | GSP 301 Placebo NS pH 7.0 | 2 | 101 | 3 |
| other | Nasal discomfort | Respiratory, thoracic and mediastinal disorders | GSP 301 NS | 11 | 393 | 15 |
| other | Nasal discomfort | Respiratory, thoracic and mediastinal disorders | GSP 301 Placebo NS pH 3.7 | 2 | 99 | 2 |
| other | Nasal discomfort | Respiratory, thoracic and mediastinal disorders | GSP 301 Placebo NS pH 7.0 | 5 | 101 | 7 |
| serious | Cholelithiasis | Hepatobiliary disorders | GSP 301 NS | 1 | 393 | 1 |
| serious | Cholelithiasis | Hepatobiliary disorders | GSP 301 Placebo NS pH 3.7 | 0 | 99 | 0 |
| serious | Cholelithiasis | Hepatobiliary disorders | GSP 301 Placebo NS pH 7.0 | 1 | 101 | 1 |
| serious | Appendicitis | Infections and infestations | GSP 301 NS | 0 | 393 | 0 |
| serious | Appendicitis | Infections and infestations | GSP 301 Placebo NS pH 3.7 | 1 | 99 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02709538/events